Clinical trials recruiting in Kisumu, Kenya

Phase breakdown

Conditions recruiting in Kisumu, Kenya

Recruiting trials in Kisumu, Kenya

• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female)
• A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
  NCT05431088 · Phase: Phase 2, Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female)
• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
  NCT07071623 · Phase: Phase 3 · Ages: 16 Years to 30 Years · Sex: Female
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
  NCT06198712 · Phase: Phase 2 · Ages: 6 Months to 18 Years · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
  NCT06439082 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female)
• Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women
  NCT06953310 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics
  NCT07089966 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model
  NCT06203951 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female
• Investigating the Optimal Management of Dolutegravir Resistance
  NCT06762054 · Phase: Not specified · Ages: 1 Year and older · Sex: All (male and female)
• Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission
  NCT07628140 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female)
• Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
  NCT06747507 · Phase: Phase 3 · Ages: 3 Years and older · Sex: All (male and female)
• One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care Project
  NCT05905640 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women
  NCT06566430 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 24 Years · Sex: Female
• Precision Imaging to Evaluate Kaposi Sarcoma
  NCT06898203 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Reaching the Last 20% (the Pamoja Kwa Afya Study)
  NCT05882916 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female

Common questions

How many clinical trials are recruiting in Kisumu, Kenya?

17 recruiting trials have at least one study site in Kisumu, Kenya.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.